Perspectives on Enquiry & Evidence

People think in Bayesian terms all the time: we use prior information and the evidence at hand to make decisions in our..

Ever since the first immune checkpoint inhibitor was approved for market nearly twelve years ago, the industry has..

Clinical researchers, seeking to understand the statistical benefits of a common Phase 2 oncology design, now have a..

A combination of industry and policy forces have recently changed the shape of Australia’s R&D sector, making it a..

Randomized control trials (RCTs) are the gold standard for estimating the efficacy of a treatment. They allow us to..

Real world evidence (RWE) provides a large and growing source of insights into drug uptake and safety. It is..

The issue of delayed treatment effects in immuno-oncology was demonstrated during a FDA-Industry sponsored workshop..

The FDA “Real-Time Oncology Review (RTOR)”[1] is an “FDA project started in 2018 to facilitate earlier submission of..

Currently, there are many treatment options for Cancer such as, Immunotherapy, Radiation Therapy, Chemotherapy etc. If..